Publications by Topic

Li, Y., Regan, M., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Miller, J., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Disparities in tuberculosis incidence by race and ethnicity among the U.S.-born population in the United States, 2011 to 2021: An analysis of national disease registry data. Annals of Internal Medicine. https://doi.org/10.7326/M23-2975

Ekramnia, M., Li, Y., Haddad, M., Marks, S., Kammerer, J., Swartwood, N., Cohen, T., Miller, J., Horsburgh, C., Salomon, J., & Menzies, N. (2024). Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology, 35(2), 164-173. https://doi.org/10.1097/EDE.0000000000001707

Regan, M., Li, Y., Swartwood, N., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: An analysis of national surveillance data. The Lancet Public Health, 9(1), e47-e56. https://doi.org/10.1016/S2468-2667(23)00276-1

Rönn, M., Li, Y., Gift, T., Chesson, H., Menzies, N., Hsu, K., & Salomon, J. (2023). Costs, health benefits, and cost-effectiveness of chlamydia screening and partner notification in the United States, 2000–2019: A mathematical modeling analysis. Sexually Transmitted Diseases, 50(6), 351-358. https://doi.org/10.1097/OLQ.0000000000001786

Pham, T., Toy, M., Hutton, D., Thompson, W., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019. Medical Care, 61(4), 247-253. https://doi.org/10.1097/MLR.0000000000001825

Pham, T., Maria, N., Cheng, V., Nguyen, B., Toy, M., Hutton, D., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps in prenatal hepatitis B screening and management of HBsAg positive pregnant persons in the United States. American Journal of Preventative Medicine, 65(1), 52-29. https://doi.org/10.1016/j.amepre.2023.01.041

You, S., Yaesoubi, R., Lee, K., Li, Y., Eppink, S., Hsu, K., Chesson, H., Gift, T., Berruti, A., Salomon, J., & Rönn, M. (2023). Lifetime quality-adjusted life years lost due to genital herpes acquired in the United States in 2018: A mathematical modeling study. Lancet Regional Health Americas, 19. https://doi.org/10.1016/j.lana.2023.100427

Klaassen, F., Chitwood, M., Cohen, T., Pitzer, V., Russi, M., Swartwood, N., Salomon, J., & Menzies, N. (2023). Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021. Clinical Infectious Diseases, 76(3), e350–e359. https://doi.org/10.1093/cid/ciac438

Reichert, E., Yaesoubi, R., Rönn, M., Gift, T., Salomon, J., & Grad, Y. (2023). Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: A mathematical modelling study. Lancet Microbe, 4(10), e781-e789. https://doi.org/10.1016/S2666-5247(23)00145-3

Swartwood, N., Testa, C., Cohen, T., Marks, S., Hill, A., Asay, G., Cochran, J., Cranston, K., Randall, L., Tibbs, A., Horsburgh, C., Salomon, J., & Menzies, N. (2023). Tabby2: A user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Medicine, 21(331). https://doi.org/10.1186/s12916-023-02785-y

Li, Y., You, S., Lee, K., Yaesoubi, R., Hsu, K., Gift, T., Chesson, H., Berruti, A., Salomon, J., & Rönn, M. (2023). The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018. Journal of Infectious Diseases, 227(8), 1007-1018. https://doi.org/10.1093/infdis/jiad047

Yaesoubi, R., Xi, Q., Hsu, K., Gift, T., Cyr, S., Rönn, M., Salomon, J., & Grad, Y. (2023). The impact of rapid drug susceptibility tests on gonorrhea burden and lifespan of antibiotic treatments: A modeling study among men who have sex with men in the United States. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwad175

So, S., Terrault, N., & Conners, E. (2023). Universal adult hepatitis B screening and vaccination as the path to elimination. JAMA, 329(19), 1639–1640. https://doi.org/10.1001/jama.2023.2806

Rönn, M., Menzies, N., & Salomon, J. (2023). Vaccination and voting patterns in the U.S.: Analysis of COVID-19 and flu surveys from 2010 to 2022. American Journal of Preventive Medicine, 65(3), 458-466. https://doi.org/10.1016%2Fj.amepre.2023.03.001

Li, Y., Rönn, M., Tuite, A., Chesson, H., Gift, T., Trikalinos, T., Testa, C., Bellerose, M., Hsu, K., Berruti, A., Malyuta, Y., Menzies, N., & Salomon, J. (2022). Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Regional Health Americas, 16. https://doi.org/10.1016/j.lana.2022.100364

Zhong, H., Brandeau, M., Yazdi, G., Wang, J., Nolen, S., Hagan, L., Thompson, W., Assoumou, S., Linas, B., & Salomon, J. (2022). Metamodeling for policy simulations with multivariate outcomes. Medical Decision Making, 42(7). https://doi.org/10.1177/0272989X221105079

Lee, K., You, S., Li, Y., Chesson, H., Gift, T., Berruti, A., Hsu, K., Yaesoubi, R., Salomon, J., & Rönn, M. (2022). Estimation of the lifetime quality-adjusted life years (QALYs) lost due to syphilis acquired in the United States in 2018. Clinical Infectious Diseases, 76(3), e810–e819. https://doi.org/10.1093/cid/ciac427

Kim, S., Cohen, T., Horsburgh, C., Miller, J., Hill, A., Marks, S., Li, R., Kammerer, J., Salomon, J., & Menzies, N. (2022). Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clinical Infectious Diseases, 74(9), 1594–1603. https://doi.org/10.1093/cid/ciab668

Yaesoubi, R., Cohen, T., Hsu, K., Gift, T., St Cyr , S., Salomon, J., & Grad, Y. (2022). Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Computational Biology, 18(2). https://doi.org/10.1371/journal.pcbi.1009842

Toy, M., Hutton, D., Harris, A., Nelson, N., Salomon, J., & So, S. (2022). Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States. Clinical Infectious Diseases, 74(215), 210–217. https://doi.org/10.1093/cid/ciab405

Menzies, N., Shrestha, S., Parriott, A., Marks, S., Hill, A., Dowdy, D., Shete, P., Cohen, T., & Salomon, J. (2022). The health and economic benefits of tests that predict future progression to tuberculosis disease. Epidemiology, 33(1), 75-83. https://doi.org/10.1097/EDE.0000000000001418

Gonsalves, G., Salomon, J., Thornhill, T., & Paltiel, A. (2022). Adventures in COVID-19 policy modeling: Education edition. Current HIV/AIDS Reports, 19(1), 94-100. https://doi.org/10.1007/s11904-021-00592-9

Hutton , D., Toy, M., Salomon, J., Conners, E., Nelson, N., Harris, A., & So, S. (2022). Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections. Sexually Transmitted Diseases, 49(7), 517-525. https://doi.org/10.1097/OLQ.0000000000001632

Chin, E., Leidner, D., Zhang, Y., Long, E., Prince, L., Schrag, S., Verani, J., Wiegand, R., Alarid-Escudero, F., Goldhaber-Fiebert, J., Studdert, D., Andrews, J., & Salomon, J. (2022). Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: Retrospective cohort study. Clinical Infectious Diseases, 75(1), e838-e845. https://doi.org/10.1093/cid/ciab1032

Bilinski, A., Ciaranello, A., Fitzpatrick, M., Giardina, J., Shah, M., Salomon, J., & Kendall, E. (2022). Estimated transmission outcomes and costs of SARS-CoV-2 diagnostic testing, screening, and surveillance strategies among a simulated population of primary school students. JAMA Pediatrics, 176(7), 679-689. https://doi.org/10.1001/jamapediatrics.2022.1326

Salomon, J., & Bilinski, A. (2022). Evaluating the performance of Centers for Disease Control and Prevention COVID-19 community levels as leading indicators of COVID-19 mortality. Annals of Internal Medicine, 175(9), 1240-1249. https://doi.org/10.7326/M22-0803

Giardina, J., Bilinski, A., Fitzpatrick, M., Kendall, E., Linas , B., Salomon, J., & Ciaranello, A. (2022). Model-estimated association between simulated US elementary school-related SARS-CoV-2 transmission, mitigation interventions, and vaccine coverage across local incidence levels. JAMA Network Open, 5(2), e2147827. https://doi.org/10.1001/jamanetworkopen.2021.47827

Haber, N., Clarke-Deelder, E., Feller, A., Smith, E., Salomon, J., MacCormack- Gelles, B., Stone, E., Bolster-Foucault, C., Daw, J., Hatfield, L., Fry, C., Boyer , C., Ben-Michael, E., Joyce, C., Linas, B., Schmid, I., Au, E., Wieten, S., Jarrett, B., Axfors, C., Nguyen, V., Griffin, B., Bilinski, A., & Stuart, E. (2022). Problems with evidence assessment in COVID-19 health policy impact evaluation: A systematic review of study design and evidence strength. BMJ Open, 12(1), e053820. https://doi.org/10.1136/bmjopen-2021-053820

Asabor , E., Warren , J., & Cohen, T. (2022). Racial/Ethnic segregation and access to COVID-19 testing: Spatial distribution of COVID-19 testing sites in the four largest highly segregated cities in the United States. American Journal of Public Health, 112(3), 518-526. https://doi.org/10.2105/AJPH.2021.306558

Bellerose, M., Zhu, L., Hagan, L., Thompson, W., Randall, L., Malyuta, Y., Salomon, J., & Linas, B. (2021). A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. International Journal of Drug Policy, 88. https://doi.org/10.1016/j.drugpo.2019.10.006

Yaesoubi, R., Havumaki, J., Chitwood, M., Menzies, N., Gonsalves, G., Salomon, J., Paltiel, A., & Cohen, T. (2021). Adaptive policies to balance health benefits and economic costs of physical distancing interventions during the COVID-19 pandemic. Medical Decision Making, 41(4), 386-392. https://doi.org/10.1177/0272989X21990371

Tuite, A., Zhu, L., Fisman, D., & Salomon, J. (2021). Alternative dose allocation strategies to increase benefits from constrained COVID-19 vaccine supply. Annals of Internal Medicine, 174(4), 570-572. https://doi.org/10.7326/M20-8137

Bilinski, A., Emanuel, E., Salomon, J., & Venkataramani, A. (2021). Better late than never: Trends in COVID-19 infection rates, risk perceptions, and behavioral responses in the USA. Journal of General Internal Medicine, 36(6), 1825-1828. https://doi.org/10.1007/s11606-021-06633-8

Chin, E., Ryckman, T., Prince, L., Leidner, D., Alarid-Escudero, F., Andrews, J., Salomon, J., Studdert, D., & Goldhaber-Fiebert , J. (2021). COVID-19 in the California state prison system: An observational study of decarceration, ongoing risks, and risk factors. Journal of General Internal Medicine, 36(10), 3096-3102. https://doi.org/10.1007/s11606-021-07022-x

Chin, E., Leidner, D., Ryckman, T., Liu, Y., Prince, L., Alarid-Escudero, F., Andrews, J., Salomon, J., Goldhaber-Fiebert, J., & Studdert, D. (2021). COVID-19 vaccine acceptance in California state prisons. New England Journal of Medicine, 385(4), 374-376. https://doi.org/doi:10.1056/NEJMc2105282

Alarid-Escudero, F., Gracia, V., Luviano, A., Roa, J., Peralta, Y., Reitsma, M., Claypool, A., Salomon, J., Studdert, D., Andrews, J., Goldhaber-Fiebert, J., & SC-COSMO Modeling Consortium, . (2021). Dependence of COVID-19 policies on end-of-year holiday contacts in Mexico City metropolitan area: A modeling study. MDM Policy & Practice, 6(2), 23814683211049249. https://doi.org/10.1177/23814683211049249

Chin, E., Leidner, D., Long, E., Prince, L., Li, Y., Andrews, J., Studdert, D., Goldhaber-Fiebert, J., & Salomon, J. (2021). Effectiveness of the mRNA-1273 vaccine during a SARS-CoV-2 Delta outbreak in a prison. New England Journal of Medicine, 385(24), 2300-2301. https://doi.org/10.1056/NEJMc2114089

Haber, N., Clarke-Deelder, E., Salomon, J., Feller, A., & Stuart, E. (2021). Impact evaluation of coronavirus disease 2019 policy: A guide to common design issues. American Journal of Epidemiology, 190(11), 2474-2486. https://doi.org/10.1093/aje/kwab185

Reitsma, M., Salomon, J., & Goldhaber-Fiebert, J. (2021). Mapping inequality in SARS-CoV-2 household exposure and transmission risk in the USA. Journal of General Internal Medicine, 36(5), 1476-1478. https://doi.org/10.1007/s11606-021-06603-0

Earnest, R., Rönn, M., Bellerose, M., Menon-Johansson, A., Berruti, A., Chesson, H., Gift, T., Hsu, K., Testa, C., Zhu, L., Malyuta, Y., Menzies, N., & Salomon, J. (2021). Modeling the cost-effectiveness of express multisite gonorrhea screening among men who have sex with men in the United States. Sexually Transmitted Diseases, 48(11), 805-812. https://doi.org/10.1097/OLQ.0000000000001467

Ryckman, T., Chin, E., Prince, L., Leidner, D., Long, E., Studdert, D., Salomon, J., Alarid-Escudero, F., Andrews, J., & Goldhaber-Fiebert, J. (2021). Outbreaks of COVID-19 variants in US prisons: A mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health, 6(10), e760-e770. https://doi.org/10.1016/S2468-2667(21)00162-6

Bilinski, A., Salomon, J., Giardina, J., Ciaranello, A., & Fitzpatrick, M. (2021). Passing the test: A model-based analysis of safe school-reopening strategies. Annals of Internal Medicine, 174(8), 1090-1100. https://doi.org/10.7326/M21-0600

Reitsma, M., Goldhaber-Fiebert, J., & Salomon, J. (2021). Quantifying and benchmarking disparities in COVID-19 vaccination rates by race and ethnicity. JAMA Network Open, 4(10), e2130343. https://doi.org/10.1001/jamanetworkopen.2021.30343

Reitsma, M., Claypool, A., Vargo, J., Shete, P., McCorvie, R., Wheeler, W., Rocha, D., Myers, J., Murray, E., Bregman, B., Dominguez, D., Nguyen, A., Porse, C., Fritz, C., Jain, S., Watt, J., Salomon, J., & Goldhaber-Fiebert, J. (2021). Racial/ethnic disparities in COVID-19 exposure risk, testing, and cases at the subcounty level in California. Health Affairs, 40(6), 870-878. https://doi.org/10.1377/hlthaff.2021.00098

Fung, H., Martinez, L., Alarid-Escudero, F., Salomon, J., Studdert, D., Andrews, J., Goldhaber-Fiebert, J., & SC-COSMO Modeling Group, . (2021). The household secondary attack rate of SARS-CoV-2: A rapid review. Clinical Infectious Diseases, 73(2), S138-S145. https://doi.org/10.1093/cid/ciaa1558

Salomon, J., Reinhart, A., Bilinski, A., Chua, E., La Motte-Kerr , W., Rönn, M., Reitsma, M., Morris, K., LaRocca, S., Farag, T., Kreuter, K. F., Rosenfeld, R., & Tibshirani, R. (2021). The US COVID-19 trends and impact survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination. Proceedings of the National Academy of Sciences, 118(51), e2111454118. https://doi.org/10.1073/pnas.2111454118

James, L., Salomon, J., Buckee, C., & Menzies, N. (2021). The use and misuse of mathematical modeling for infectious disease policymaking: Lessons for the COVID-19 pandemic. Medical Decision Making, 41(4), 379-385. https://doi.org/10.1177/0272989X21990391

Menzies, N., Swartwood, N., Testa, C., Malyuta, Y., Hill, A., Marks, S., Cohen, T., & Salomon, J. (2021). Time since infection and risks of future disease for individuals with mycobacterium tuberculosis infection in the United States. Epidemiology, 32(1), 70-78. https://doi.org/10.1097/EDE.0000000000001271

Yaesoubi, R., Cohen, T., Hsu, K., Gift, T., Chesson, H., Salomon, J., & Grad, Y. (2020). Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study. PLoS Medicine, 17(4), e1003077. https://doi.org/10.1371/journal.pmed.1003077

Menzies, N., Parriott, A., Shrestha, S., Dowdy, D., Cohen, T., Salomon, J., Marks, S., Hill, A., Winston, C., Asay, G., Barry, P., Readhead, A., Flood, J., Kahn, J., & Shete, P. (2020). Comparative modeling of tuberculosis epidemiology and policy outcomes in California. American Journal of Respiratory and Critical Care Medicine, 201(3), 356-365. https://doi.org/10.1164/rccm.201907-1289OC

Assoumou, S., Tasillo, A., Vellozzi, C., Eftekhari Yazdi, G., Wang, J., Nolen, S., Hagan, L., Thompson, W., Randall, L., Strick, L., Salomon, J., & Linas, B. (2020). Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons. Clinical Infectious Diseases, 70(7), 1388-1396. https://doi.org/10.1093/cid/ciz383

Bilinski, A., & Emanuel, E. (2020). COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA, 324(20), 2100-2102. https://doi.org/10.1001/jama.2020.20717

Shrestha, S., Parriott, A., Menzies, N., Shete, P., Hill, A., Marks, S., & Dowdy, D. (2020). Estimated population-level impact of using a six-week regimen of daily Rifapentine to treat latent tuberculosis infection in the United States. Annals of the American Thoracic Society, 17(12), 1639-1642. https://doi.org/10.1513/AnnalsATS.202005-574RL

Zhu, L., Menzies, N., Wang, J., Linas, B., Goodreau, S., & Salomon, J. (2020). Estimation and correction of bias in network simulations based on respondent-driven sampling data. Scientific Reports, 10(1), 6348. https://doi.org/10.1038/s41598-020-63269-0

Tuite, A., Testa, C., Rönn, M., Bellerose, M., Gift, T., Fridge, J., Molotnikov, L., Desmarais, C., Berruti, A., Menzies, N., Malyuta, Y., Hsu, K., & Salomon, J. (2020). Exploring how epidemic context influences syphilis screening impact: A mathematical modeling study. Sexually Transmitted Diseases, 47(12), 798-810. https://doi.org/10.1097/OLQ.0000000000001249

Assoumou, S., Wang, J., Nolen, S., Eftekhari Yazdi , G., Mayer, K., Puro, J., Salomon, J., & Linas, B. (2020). HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic. Journal of General Internal Medicine, 35(5), 1477-1483. https://doi.org/10.1007/s11606-020-05701-9

Assoumou, S., Nolen, S., Hagan, L., Wang, J., Eftekhari Yazdi, G., Thompson, W., Mayer, K., Puro, J., Zhu, L., Salomon, J., & Linas, B. (2020). Hepatitis C management at federally qualified health centers during the opioid epidemic: A cost-effectiveness study. American Journal of Medicine, 133(11), e641-e658. https://doi.org/10.1016/j.amjmed.2020.05.029

Hill, A., Cohen, T., Salomon, J., & Menzies, N. (2020). High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics, 33. https://doi.org/10.1016/j.epidem.2020.100419

Menzies, N., Bellerose, M., Testa, C., Swartwood, N., Malyuta, Y., Cohen, T., Marks, S., Hill, A., Date, A., Maloney, S., Bowden, S., Grills, A., & Salomon, J. (2020). Impact of effective global tuberculosis control on health and economic outcomes in the United States. American Journal of Respiratory and Critical Care Medicine, 202(11), 1567-1575. https://doi.org/10.1164/rccm.202003-0526OC

Rönn, M., Dunville, R., Wang, L., Bellerose, M., Malyuta, Y., Menzies, N., Aslam, M., Lewis, F., Walker-Baban, C., Asbel, L., Parchem, S., Masinter, L., Perez, E., Gift, T., Hsu, K., Barrios, L., & Salomon, J. (2020). Mathematical modeling study of school-based chlamydia screening: Potential impact on chlamydia prevalence in intervention schools and surrounding communities. BMC Public Health, 20(1), 1363. https://doi.org/10.1186/s12889-020-09466-y

Bilinski, A., Mostashari, F., & Salomon, J. (2020). Modeling contact tracing strategies for COVID-19 in the context of relaxed physical distancing measures. JAMA Network Open, 3(8), e2019217. https://doi.org/10.1001/jamanetworkopen.2020.19217

Kreuter, F., Barkay, N., Bilinski, A., Bradford, A., Chiu, S., Eliat, R., Fan, J., Galili, T., Haimovich, D., Kim, B., LaRocca, S., Li, Y., Morris, K., Presser, S., Salomon, J., Sarig, T., Stewart, K., Stuart, E., & Tibshirani, R. (2020). Partnering with Facebook on a university-based rapid turn-around global survey. Survey Research Methods, 14(2), 159-163. https://doi.org/10.18148/srm/2020.v14i2.7761

Marks, S., Dowdy, D., Menzies, N., Shete, P., Salomon, J., Parriott, A., Shrestha, S., Flood, J., & Hill, A. (2020). Policy implications of mathematical modeling of latent tuberculosis infection testing and treatment strategies to accelerate tuberculosis elimination. Public Health Reports, 135, 38S-43S. https://doi.org/10.1177/0033354920912710

Earnest, R., Rönn, M., Bellerose, M., Gift, T., Berruti, A., Hsu, K., Testa, C., Zhu, L., Malyuta, Y., Menzies, N., & Salomon, J. (2020). Population-level benefits of extragenital gonorrhea screening among men who have sex with men: An exploratory modeling analysis. Sexually Transmitted Diseases, 47(7), 484-490. https://doi.org/10.1097/OLQ.0000000000001189

Rönn, M., Menzies, N., Gift, T., Chesson, H., Trikalinos, T., Bellerose, M., Malyuta, Y., Berruti, A., Gaydos, C., Hsu, K., & Salomon, J. (2020). Potential for point-of-care tests to reduce chlamydia-associated burden in the United States: A mathematical modeling analysis. Clinical Infectious Diseases, 70(9), 1816-1823. https://doi.org/10.1093/cid/ciz519

Rönn, M., Testa, C., Tuite, A., Chesson, H., Gift, T., Schumacher, C., Williford, S., Zhu, L., Bellerose, M., Earnest, R., Malyuta, Y., Hsu, K., Salomon, J., & Menzies, N. (2020). The potential population-level impact of different gonorrhea screening strategies in Baltimore and San Francisco: An exploratory mathematical modeling analysis. Sexually Transmitted Diseases, 47(3), 143-150. https://doi.org/10.1097/OLQ.0000000000001108

Assoumou, S., Wang, J., Tasillo, A., Eftekhari Yazdi , G., Tsui, J., Strick, L., & Linas, B. (2019). Hepatitis C testing and patient characteristics in Washington state’s prisons between 2012 and 2016. American Journal of Preventative Medicine, 56(1), 8-16. https://doi.org/10.1016/j.amepre.2018.08.016

Epstein, R., Wang, J., Hagan, L., Mayer, K., Puro, J., Linas, B., & Assoumou, S. (2019). Hepatitis C virus antibody testing among 13- to 21-year-olds in a large sample of US federally qualified health centers. JAMA, 322(22), 2245-2248. https://doi.org/10.1001/jama.2019.16196

Tasillo, A., Eftekhari Yazdi, G., Nolen, S., Schillie, S., Vellozzi, C., Epstein, R., Randall, L., Salomon, J., & Linas, B. (2019). Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care. Obstetrics and Gynecology, 133(2), 289-300. https://doi.org/10.1097/AOG.0000000000003062

Rönn, M., Tuite, A., Menzies, N., Wolf, E., Gift, T., Chesson, H., Torrone, E., Berruti, A., Mazzola, A., Galer, K., Hsu, K., & Salomon, J. (2019). The impact of screening and partner notification on chlamydia prevalence and numbers of infections averted in the United States, 2000–2015: Evaluation of epidemiologic trends using a pair-formation transmission model. American Journal of Epidemiology, 188(3), 545-554. https://doi.org/10.1093/aje/kwy272

Tuite, A., Rönn, M., Wolf, E., Gift, T., Chesson, H., Berruti, A., Galer, K., Menzies, N., Hsu, K., & Salomon, J. (2018). Estimated impact of screening on gonorrhea epidemiology in the United States: Insights from a mathematical model. Sexually Transmitted Diseases, 45(11), 713-722. https://doi.org/10.1097/OLQ.0000000000000876

Menzies, N., Cohen, T., & Salomon, J. (2018). Evidence sources on the natural history of latent tuberculosis infection. Lancet Infectious Diseases, 18(8), 834-835. https://doi.org/10.1016/S1473-3099(18)30406-7

Epstein, R., Wang, J., Mayer, K., Puro, J., Horsburgh, C., Linas, B., & Assoumou, S. (2018). HCV screening practices among adolescents and young adults in a national sample of federally qualified health centers in the United States. Open Forum Infectious Diseases, 5, S74. https://doi.org/10.1093/ofid/ofy209.178

Epstein, R., Sabharwal, V., Wachman, E., Saia, K., Vellozzi, C., Hariri, S., & Linas, B. (2018). Perinatal transmission of hepatitis C virus: Defining the cascade of care. Journal of Pediatrics, 203, 34-40.e1. https://doi.org/10.1016/j.jpeds.2018.07.006

Barocas, J., Tasillo, A., Eftekhari Yazdi, G., Wang, J., Vellozzi, C., Hariri, S., Isenhour, C., Randall, L., Ward, J., Mermin, J., Salomon, J., & Linas, B. (2018). Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States. Clinical Infectious Diseases, 67(4), 549-556. https://doi.org/10.1093/cid/ciy098

Menzies, N., Wolf, E., Connors, D., Bellerose, M., Sbarra, A., Cohen, T., Hill, A., Yaesoubi, R., Galer, K., White, P., Abubakar, I., & Salomon, J. (2018). Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infectious Diseases, 18(8), e228-e238. https://doi.org/10.1016/S1473-3099(18)30134-8

Menzies, N., Cohen, T., Hill, A., Yaesoubi, R., Galer, K., Wolf, E., Marks, S., & Salomon, J. (2018). Prospects for tuberculosis elimination in the United States: Results of a transmission dynamic model. American Journal of Epidemiology, 187(9), 2011-2020. https://doi.org/10.1093/aje/kwy094

Menzies, N., Hill, A., Cohen, T., & Salomon, J. (2018). The impact of migration on tuberculosis in the United States. International Journal of Tuberculosis and Lung Disease, 22(12), 1392-1403. https://doi.org/10.5588/ijtld.17.0185

Tasillo, A., Salomon, J., Trikalinos, T., Horsburgh, C., Marks, S., & Linas, B. (2017). Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model. JAMA Internal Medicine, 177(12), 1755-1764. https://doi.org/10.1001/jamainternmed.2017.3941

Barocas, J., Wang, J., White, L., Tasillo, A., Salomon, J., Freedberg, K., & Linas, B. (2017). Hepatitis C testing increased among baby boomers following the 2012 change to CDC testing recommendations. Health Affairs, 36(12), 2142-2150. https://doi.org/10.1377/hlthaff.2017.0684

Tuite, A., Gift, T., Chesson, H., Hsu, K., Salomon, J., & Grad, Y. (2017). Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea. Journal of Infectious Diseases, 216(9), 1141-1149. https://doi.org/10.1093/infdis/jix450

Neilan, A., Dunville, R., Ocfemia, M., Salomon, J., Francke, J., Wang, L., Bulteel, A., Hsu, K., DiNenno, E., Parker, R., & Walensky, R. (2017). Screening adolescents and young adults for HIV in the United States: A cost-effectiveness analysis. Journal of Adolescent Health, 60(2), S18. https://doi.org/10.1016/j.jadohealth.2016.10.055

Rönn, M., Wolf, E., Chesson, H., Menzies, N., Galer, K., Gorwitz, R., Gift, T., Hsu, K., & Salomon, J. (2017). The use of mathematical models of chlamydia transmission to address public health policy questions: A systematic literature review. Sexually Transmitted Diseases, 44(5), 278-283. https://doi.org/10.1097/OLQ.0000000000000598